Literature DB >> 20351277

Modulation of mismatch repair and genomic stability by miR-155.

Nicola Valeri1, Pierluigi Gasparini, Muller Fabbri, Chiara Braconi, Angelo Veronese, Francesca Lovat, Brett Adair, Ivan Vannini, Francesca Fanini, Arianna Bottoni, Stefan Costinean, Sukhinder K Sandhu, Gerard J Nuovo, Hansjuerg Alder, Roberta Gafa, Federica Calore, Manuela Ferracin, Giovanni Lanza, Stefano Volinia, Massimo Negrini, Michael A McIlhatton, Dino Amadori, Richard Fishel, Carlo M Croce.   

Abstract

Inactivation of mismatch repair (MMR) is the cause of the common cancer predisposition disorder Lynch syndrome (LS), also known as hereditary nonpolyposis colorectal cancer (HNPCC), as well as 10-40% of sporadic colorectal, endometrial, ovarian, gastric, and urothelial cancers. Elevated mutation rates (mutator phenotype), including simple repeat instability [microsatellite instability (MSI)] are a signature of MMR defects. MicroRNAs (miRs) have been implicated in the control of critical cellular pathways involved in development and cancer. Here we show that overexpression of miR-155 significantly down-regulates the core MMR proteins, hMSH2, hMSH6, and hMLH1, inducing a mutator phenotype and MSI. An inverse correlation between the expression of miR-155 and the expression of MLH1 or MSH2 proteins was found in human colorectal cancer. Finally, a number of MSI tumors with unknown cause of MMR inactivation displayed miR-155 overexpression. These data provide support for miR-155 modulation of MMR as a mechanism of cancer pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351277      PMCID: PMC2872463          DOI: 10.1073/pnas.1002472107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Lynch syndrome: form, function, proteins, and basketball.

Authors:  C Richard Boland; Richard Fishel
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

2.  Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.

Authors:  L A Aaltonen; R Salovaara; P Kristo; F Canzian; A Hemminki; P Peltomäki; R B Chadwick; H Kääriäinen; M Eskelinen; H Järvinen; J P Mecklin; A de la Chapelle
Journal:  N Engl J Med       Date:  1998-05-21       Impact factor: 91.245

3.  DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSalpha/hMutSbeta ratio and reduces the efficiency of base-base mismatch repair.

Authors:  J T Drummond; J Genschel; E Wolf; P Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

4.  Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability.

Authors:  Karsten Schulmann; Yuriko Mori; Victoria Croog; Jing Yin; Andreea Olaru; Anca Sterian; Fumiaki Sato; Suna Wang; Yan Xu; Elena Deacu; Agnes T Berki; James P Hamilton; Takatsugu Kan; John M Abraham; Wolff Schmiegel; Noam Harpaz; Stephen J Meltzer
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

5.  Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1.

Authors:  J M Wheeler; N E Beck; H C Kim; I P Tomlinson; N J Mortensen; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

6.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Authors:  Heather Hampel; Wendy L Frankel; Edward Martin; Mark Arnold; Karamjit Khanduja; Philip Kuebler; Hidewaki Nakagawa; Kaisa Sotamaa; Thomas W Prior; Judith Westman; Jenny Panescu; Dan Fix; Janet Lockman; Ilene Comeras; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

Review 7.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

8.  Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.

Authors:  J G Herman; A Umar; K Polyak; J R Graff; N Ahuja; J P Issa; S Markowitz; J K Willson; S R Hamilton; K W Kinzler; M F Kane; R D Kolodner; B Vogelstein; T A Kunkel; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms.

Authors:  Claire Borie; Chrystelle Colas; Peggy Dartigues; Thierry Lazure; Patricia Rince; Olivier Buhard; Patrick Folliot; Alexandra Chalastanis; Martine Muleris; Richard Hamelin; Dominique Mercier; Carla Oliveira; Raquel Seruca; Amy Chadburn; Véronique Leblond; Stéphane Barete; Gianluca Gaïdano; Antoine Martin; Philippe Gaulard; Jean-François Fléjou; Martine Raphael; Alex Duval
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

Review 10.  Mutations associated with HNPCC predisposition -- Update of ICG-HNPCC/INSiGHT mutation database.

Authors:  Päivi Peltomäki; Hans Vasen
Journal:  Dis Markers       Date:  2004       Impact factor: 3.434

View more
  141 in total

1.  Modulation of microRNA processing by mismatch repair protein MutLα.

Authors:  Guogen Mao; Sanghee Lee; Janice Ortega; Liya Gu; Guo-Min Li
Journal:  Cell Res       Date:  2012-01-31       Impact factor: 25.617

2.  MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2).

Authors:  Nicola Valeri; Pierluigi Gasparini; Chiara Braconi; Alessio Paone; Francesca Lovat; Muller Fabbri; Khlea M Sumani; Hansjuerg Alder; Dino Amadori; Tushar Patel; Gerard J Nuovo; Richard Fishel; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

3.  Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications.

Authors:  Frank A Sinicrope; Daniel J Sargent
Journal:  Clin Cancer Res       Date:  2012-02-02       Impact factor: 12.531

Review 4.  The role of microRNAs in colorectal cancer.

Authors:  Aaron J Schetter; Hirokazu Okayama; Curtis C Harris
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

5.  Investigation of microRNA expression and DNA repair gene transcripts in human oocytes and blastocysts.

Authors:  P Tulay; R P Naja; O Cascales-Roman; A Doshi; P Serhal; S B SenGupta
Journal:  J Assist Reprod Genet       Date:  2015-10-05       Impact factor: 3.412

Review 6.  Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer.

Authors:  Timothy Ming-Hun Wan; Deepak Narayanan Iyer; Lui Ng
Journal:  Histol Histopathol       Date:  2019-10-16       Impact factor: 2.303

7.  Novel diet-related mouse model of colon cancer parallels human colon cancer.

Authors:  Anil R Prasad; Shilpa Prasad; Huy Nguyen; Alexander Facista; Cristy Lewis; Beryl Zaitlin; Harris Bernstein; Carol Bernstein
Journal:  World J Gastrointest Oncol       Date:  2014-07-15

Review 8.  How microRNAs influence both hereditary and inflammatory-mediated colon cancers.

Authors:  Jennifer Hutchison; Zoe Cohen; Benjamin C Onyeagucha; Janet Funk; Mark A Nelson
Journal:  Cancer Genet       Date:  2013-09-14

9.  miR-155 drives oncogenesis by promoting and cooperating with mutations in the c-Kit oncogene.

Authors:  Lisa W Witten; Christopher J Cheng; Frank J Slack
Journal:  Oncogene       Date:  2018-11-20       Impact factor: 9.867

10.  Apoptotic Effects of Quercitrin on DLD-1 Colon Cancer Cell Line.

Authors:  Zeynep Birsu Cincin; Miray Unlu; Bayram Kiran; Elif Sinem Bireller; Yusuf Baran; Bedia Cakmakoglu
Journal:  Pathol Oncol Res       Date:  2014-08-06       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.